Harvard Bioscience (HBIO) Capital Expenditures (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Capital Expenditures of $426000.0 for Q1 2026, down 16.96% year-over-year from $513000.0 in Q1 2025, and down 5.12% quarter-over-quarter from $449000.0 in Q4 2025.
Harvard Bioscience (HBIO) Capital Expenditures (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Capital Expenditures for 17 consecutive years, with $426000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 16.96% year-over-year to $426000.0; the TTM figure through Mar 2026 stood at $1.2 million (down 53.38% YoY), while the FY2025 annual figure was $1.3 million, down 52.42% from the prior year.
- Capital Expenditures slipped to $426000.0 in Q1 2026 per HBIO's latest filing, from $449000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $880000.0 in Q3 2024 and bottomed at $89000.0 in Q2 2025.
- Historically, Capital Expenditures has averaged $453294.1 across 5 years, with a median of $442000.0 in 2022.
- Annual changes were most pronounced in 2024 — Capital Expenditures surged 305.53% — and 2025, when it plunged 89.12%.
- Harvard Bioscience's Capital Expenditures stood at $235000.0 in 2022, then soared by 253.19% to $830000.0 in 2023, then sank by 63.73% to $301000.0 in 2024, then jumped by 49.17% to $449000.0 in 2025, then retreated by 5.12% to $426000.0 in 2026.
- Business Quant data shows HBIO's Capital Expenditures at $426000.0 in Q1 2026, $449000.0 in Q4 2025, and $207000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 688,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 688,000.00 |
| Jun 30, 2026 | 688,000.00 |
| Mar 31, 2026 | 426,000.00 |
| Mar 31, 2026 | 426,000.00 |
| Dec 31, 2025 | 449,000.00 |
| Dec 31, 2025 | 449,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Mar 31, 2025 | 513,000.00 |
| Mar 31, 2025 | 513,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Sep 30, 2024 | 880,000.00 |
| Sep 30, 2024 | 880,000.00 |
| Jun 30, 2024 | 818,000.00 |
| Jun 30, 2024 | 818,000.00 |
| Mar 31, 2024 | 645,000.00 |
| Mar 31, 2024 | 645,000.00 |